DeGaynor reported significant operational actions, including headcount reduction of over 500, $9 million in SG&A reductions, $11 million in freight savings, and a reset of nearly all executive ...

The new chief executive of Stellantis faces a mountain of problems, and it’s too early for investors to go bottom fishing in ...

U.S. stock futures edged lower Monday as investors turned cautious ahead of a looming trade deadline set by President Donald Trump. With the July deadline for negotiations approaching, traders are ...

Geo Group (NYSE: GEO) stock soared 7.5% and CoreCivic (NYSE: CXW) gained 2.7% after the passing of Trump’s tax-and-spending ...

The automaker aims to sell five-, seven- and 10-year dollar bonds and raise a minimum of $750 million in each tranche.

Stellantis’ U.S. shares dipped nearly 5% in premarket trading Monday after Bank of America (BofA) downgraded the stock to Neutral from Buy, citing concerns about its European business and weak ...

Wolfe Research lowered its rating on Stellantis (NYSE:STLA) to Underperform on Wednesday, highlighting significant risks to ...

The company that owns Chrysler, Dodge, Jeep, Ram and Fiat reported a 10% decrease in sales in 2025's second quarter.

Investing.com -- Wolfe Research downgraded Stellantis (NYSE: STLA) to Underperform in a note Wednesday, citing structural challenges and macroeconomic headwinds that could weigh on earnings and free ...

KakaoPay stock plunged over 10% after trading resumed, following a regulatory warning over volatility and stablecoin speculation.

Valuation Concerns All that being said, the real concern for Palantir stock is its valuation. Palantir trades at nearly 190x consensus 2026 earnings and about 66x revenues.

Mizuho downgrades Adaptimmune stock on solvency concernsInvesting.com - Mizuho downgraded Adaptimmune Therapeutics plc (NASDAQ: ADAP) stock rating from Outperform to Neutral on Wednesday, slashing its ...